Abstract
The feasibility of using the BVS in chronic total occlusions (CTO) lesions is unknown. This study sought to assess the safety, performance and efficacy of the Absorb everolimus-eluting bioresorbable vascular scaffold (BVS), in percutaneous CTO revascularization, under guidance of imaging techniques
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
